Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer – Results of a large multicenter analysis-Reference-Cited by-同舟云学术

Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer – Results of a large multicenter analysis

Published:2023-04 Issue: Volume:181 Page:109380
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Roesch Johannes,Oertel Michael,Wegen Simone,Trommer Maike,Schleifenbaum Julia,Hering Dominik,Mäurer Matthias,Knippen Stefan,Dobiasch Sophie,Waltenberger Maria,von der Grün Jens,Medenwald Daniel,Süß Christoph,Hoeck Michael,Käsmann Lukas,Fleischmann Daniel F.,Rühle Alexander,Nicolay Nils H.,Fabian Alexander,Löser Anastassia,Heß Sebastian,Tamaskovics Bálint,Vinsensia Maria,Hecht Markus

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference44 articles.

1. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99–02): an open-label phase 3 randomised trial;Bourhis;Lancet Oncol,2012

2. LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial;Bourhis;Ann Oncol,2021

3. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors;Buglione;Tumori J,2015

4. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study;Burtness;The Lancet,2019

5. Volume, dose, and fractionation considerations for IMRT-based reirradiation in head and neck cancer: a multi-institution analysis;Caudell;Int J Radiat Oncol,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reirradiation in head and neck squamous cell carcinoma; prognostic indicators, oncologic and functional outcomes;American Journal of Otolaryngology;2024-11

2. Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapy;International Journal of Cancer;2024-08-30

3. Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer;Radiotherapy and Oncology;2024-07

4. Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives;Frontiers in Oncology;2024-01-04

5. Efficacy and safety analysis in metastatic cancer patients treated with multiple courses of repeat radiation therapy;Clinical and Translational Radiation Oncology;2023-11